ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,431.66
0.14%
Dow Jones
40,003.59
0.00%
Gold vs US Dollar
2,422.73
0.13%
Brent Oil
83.425
-0.20%
Bitcoin
66,965.77
1.22%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pharvaris NV (PHVS) Share Price

PHVS Pharvaris NV

20.35
0.00 (0.00%)
Pre Market
Last Updated: 09:09:39
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Pharvaris NV NASDAQ:PHVS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 20.35 8.14 32.35 0.00 0.00   08:09:39   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -100.88M -2.4710 -8.24 830.75M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore PHVS News
13/05/202411:50GLOBEPharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
08/05/202421:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/05/202421:10GLOBEPharvaris Reports First Quarter 2024 Financial Results and Provides Business Update
10/04/202421:10GLOBEPharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
10/04/202421:08GLOBEPharvaris Appoints David Nassif, J.D., as Chief Financial Officer
04/04/202411:50GLOBEPharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
18/03/202410:50GLOBEPharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
Period
Draw mode
Data Downloads for PHVS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Pharvaris NV Articles